Literature DB >> 32284102

Surgical and Percutaneous Interventions for Chronic Thromboembolic Pulmonary Hypertension.

William R Auger1.   

Abstract

The treatment of chronic thromboembolic pulmonary hypertension has expanded considerably. The ability to endarterectomize chronic thromboembolic material, the availability of pulmonary hypertension medical therapy to treat inoperable chronic thromboembolic pulmonary hypertension and/or residual pulmonary hypertension, and the rebirth of pulmonary balloon angioplasty have changed the management landscape. Patient selection requires a multidisciplinary evaluation at an experienced center. What is inoperable chronic thromboembolic pulmonary hypertension to one group may be operable chronic thromboembolic pulmonary hypertension to another. The ultimate challenge then becomes which intervention provides the optimal long-term outcome for any individual patient.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Balloon pulmonary angioplasty; Chronic thromboembolic pulmonary hypertension; Chronic thromboembolism; Pulmonary thromboendarterectomy; WHO group IV pulmonary hypertension

Mesh:

Year:  2020        PMID: 32284102     DOI: 10.1016/j.ccl.2020.01.003

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  1 in total

1.  A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension.

Authors:  Gudula J A M Boon; Wilbert B van den Hout; Stefano Barco; Harm Jan Bogaard; Marion Delcroix; Menno V Huisman; Stavros V Konstantinides; Lilian J Meijboom; Esther J Nossent; Petr Symersky; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  ERJ Open Res       Date:  2021-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.